close :

:

Forgotten your password?
 

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.

Daily MedNews

-- Here are the latest clinical trials, courtesy of CenterWatch: Neuropathy If you have a diagnosis of orthostatic hypotension associated with: Parkinson's disease, multiple system atrophy, pure autonomic failure, dopamine beta hydroxylase...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Experts Worried Over Rising HIV Rates Among U.S. Hispanics Increasing rates of HIV/AIDS among Hispanics in the United States point to a simmering...
-- Pesticides can help keep your home free of insects, rodents and other unwanted visitors, but exposure to these products can pose serious health risks. The National Safety Council offers these suggestions when working with pesticides: Only use...
THURSDAY, July 24 -- When the elderly woman first arrived at Brooke Grove Retirement Village in Sandy Spring, Md., some of the staffers were skeptical when they saw she had brought her cat along. The woman, in the early stages of dementia, "floated...
-- If you don't carefully monitor your diet, here are a few warning signs that you should, courtesy of the American Academy of Family Physicians: If your doctor has warned you about health problems or risk factors that can be controlled or improved...

More...

Pharma Industry News

PRINCETON, N.J., July 24, 2008 - Pharmacopeia (NASDAQ: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it has identified a new lead for advancement in its alliance with...
NEW YORK--(BUSINESS WIRE)--Jul 24, 2008 - Bristol-Myers Squibb Company (NYSE:BMY) today reported very strong sales and earnings growth for the second quarter 2008 and announced additional plans to proactively manage costs. "We are making measurable...
Company reports double-digit sales and earnings growth INDIANAPOLIS, July 24, 2008 /PRNewswire-FirstCall/ -- Eli Lilly and Company today announced financial results for the second quarter of 2008. Second-quarter results are presented on a reported...
HUENENBERG, Switzerland--(BUSINESS WIRE)--Jul 23, 2008 - Alcon, Inc. (NYSE:ACL) reported global sales of $1,735.2 million for the second quarter of 2008, an increase of 17.9 percent compared to the second quarter of 2007, or 11.2 percent excluding...
Despite stagnant erythropoietin (EPO) sales, four new EPO products were introduced in Europe during the last year, but the pipeline shifts from biosimilar based approaches to next generation erythropoiesis stimulating agents (ESA) BARCELONA, Spain,...

More...

New Drug Approvals

ALAMEDA, Calif.--(BUSINESS WIRE)--Jul 18, 2008 - Celera today announced that it has received marketing clearance from the U.S. Food and Drug Administration for its 510(k) submission of the ViroSeq HIV-1 Genotyping System Software v2.8. The...
COLUMBUS, Ohio, July 14, 2008 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its New Drug Application (NDA) for Morphine Sulfate Tablets and Oral Solution CII by the U.S. Food and Drug Administration. Roxane...
CARLSBAD, Calif.--(BUSINESS WIRE)--Jul 8, 2008 - Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, today announced it has received U.S. Food and Drug Administration...
First Organ-specific MRI Contrast Agent Approved in the United States in More Than a Decade WAYNE, N.J., July 08, 2008 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and...
LIBERTY CORNER, N.J., July 03, 2008 /PRNewswire/ -- On June 27, 2008 GeneraMedix Inc. received approval from the U.S. Food and Drug Administration (FDA) for its Epoprostenol for Injection 1.5 mg New Drug Application (NDA). Epoprostenol for...

More...

New Drug Applications

PRINCETON, N.J. & LONDON--(BUSINESS WIRE)--July 23, 2008--Bristol-Myers Squibb Company and AstraZeneca today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) on June 30th and validation of a...
EAST WINDSOR, N.J.--(BUSINESS WIRE)--July 22, 2008 - NexMed, Inc. today announced the receipt of a non approvable letter from the U.S. Food and Drug Administration (FDA) in response to its New Drug Application (NDA) for its topical treatment for...
NEWPORT, Ky.--(BUSINESS WIRE)--Jul 22, 2008 - Xanodyne Pharmaceuticals, Inc. announced today that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Zipsor, its candidate for the treatment of patients with mild...
ATLANTA--(BUSINESS WIRE)--Jul 16, 2008 - Sciele Pharma, Inc. today announced that the U.S. Food & Drug Administration (FDA) has issued an approvable letter for the head lice treatment. Sciele Pharma is working closely with Summers Laboratories...
THOUSAND OAKS, Calif., July 14, 2008 — Biotechnology company Amgen Inc. said Business Wire erroneously released a statement from the company Monday, saying the Food and Drug Administration approved its Nplate treatment for a rare type of...

More...

Clinical Trials

SAN DIEGO--(BUSINESS WIRE)--Jul 24, 2008 - Aethlon Medical, Inc. (OTCBB:AEMD) disclosed today that a peer reviewed scientific paper coauthored by Aethlon researchers has been published in the Journal of Translational Medicine. The paper entitled,...
MEXICO CITY, July 24, 2008 /PRNewswire/ -- New research from the Journal of the American Medical Association (JAMA) theme issue on HIV/AIDS will be released to the media, coinciding with the International AIDS Conference. Four of the world's top...
CAMBRIDGE, July 24, 2008: Alizyme plc (LSE: AZM) (“Alizyme”) today announces headline results of its European Phase III clinical trial of Colal-Pred in patients with moderate to severe ulcerative colitis. Highlights • Results...
WASHINGTON, DC (Tuesday, July 22, 2008) — For patients receiving kidney transplants, treatment with cholesterol-lowering "statin" drugs may lead to longer survival, reports a study in the November 2008 Journal of the American Society of...
NEW YORK, July 24, 2008 /PRNewswire-FirstCall/ -- MacroChem Corporation today announced results of a Phase 2 clinical trial involving 37 patients who completed a 48-week, U.S. multi-center, open-label efficacy and safety study of EcoNail, a topical...

More...

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
July 14, 2008
Audience: Oncologists, other healthcare professionals[Posted 07/14/2008] Genentech, Inc. informed healthcare professionals of...
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...